Cordatus Wealth Management LLC Dexcom Inc Transaction History

Cordatus Wealth Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$106.71 - $143.18 $217,048 - $291,228	-2,034 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$84.79 - $104.74 $14,499 - $17,910	171 Added 9.18%	2,034 $731,000
Q4 2020 Feb 02, 2021	BUY	$78.0 - $104.5 $4,680 - $6,270	60 Added 3.33%	1,863 $689,000
Q3 2020 Oct 23, 2020	BUY	$95.51 - $112.95 $955 - $1,129	10 Added 0.56%	1,803 $743,000
Q2 2020 Jul 21, 2020	SELL	$62.68 - $105.34 $98,407 - $165,383	-1,570 Reduced 46.68%	1,793 $727,000
Q1 2020 Apr 21, 2020	BUY	$47.79 - $75.63 $160,717 - $254,343	3,363 New	3,363 $906,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Cordatus Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Cordatus Wealth Management LLC with notifications on news.